Christopher Nowers
Chief Executive Officer at ONK Therapeutics Ltd.
Christopher Nowers active positions
Companies | Position | Start | End |
---|---|---|---|
ONK Therapeutics Ltd.
ONK Therapeutics Ltd. BiotechnologyHealth Technology ONK Therapeutics Ltd. develops bio cells for anti cancer therapies. The company was founded by Michael O'Dwyer and Anthony Killarney in 2015 and is headquartered in Galway, Ireland. | Director/Board Member | 30/09/2020 | - |
Chief Executive Officer | 30/09/2020 | - |
Career history of Christopher Nowers
Former positions of Christopher Nowers
Companies | Position | Start | End |
---|---|---|---|
AVANTOGEN ONCOLOGY, INC. | Chief Executive Officer | - | 29/04/2007 |
Kuur Therapeutics Ltd.
Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | Director/Board Member | 31/07/2018 | - |
Chief Executive Officer | 31/07/2018 | - | |
AMGEN INC. | Corporate Officer/Principal | - | - |
GENOMIC HEALTH, INC. | Sales & Marketing | - | - |
KITE PHARMA INC | Corporate Officer/Principal | 13/10/2016 | - |
Statistics
International
United States | 5 |
United Kingdom | 2 |
Ireland | 2 |
Operational
Chief Executive Officer | 3 |
Corporate Officer/Principal | 2 |
Director/Board Member | 2 |
Sectoral
Health Technology | 7 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
AMGEN INC. | Health Technology |
Private companies | 5 |
---|---|
Avantogen Oncology, Inc.
Avantogen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Avantogen Oncology, Inc. operates as a development stage company. It is engaged in the acquisition and development of novel compounds to treat patients with various types of cancer. The company was founded in 1986 and is headquartered in Pasadena, CA. | Health Technology |
Kite Pharma, Inc.
Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
Genomic Health, Inc.
Genomic Health, Inc. Medical SpecialtiesHealth Technology Genomic Health, Inc. engages in the provision of genomic-based diagnostic tests. Its tests analyze the underlying biology of cancers, allowing physicians and patients to make individualized treatment decisions. The firm uses a platform which translates a massive amount of clinical and genomic data into clinically actionable results for treatment planning. The company was founded by Patrick F. Terry, Joffre B. Baker, Randal W. Scott, and Steven Shak in August 2000 and is headquartered in Redwood City, CA. | Health Technology |
Kuur Therapeutics Ltd.
Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | Health Technology |
ONK Therapeutics Ltd.
ONK Therapeutics Ltd. BiotechnologyHealth Technology ONK Therapeutics Ltd. develops bio cells for anti cancer therapies. The company was founded by Michael O'Dwyer and Anthony Killarney in 2015 and is headquartered in Galway, Ireland. | Health Technology |
- Stock Market
- Insiders
- Christopher Nowers
- Experience